Ratings by Wolfe Research (Doug Schenkel)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/4/2026 | Twist Bioscience | TWST | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2026 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2025 | Bruker | BRKR | Upgrade | Outperform (Peerperform) |
45.36 (55.11) |
21.49% | Details | |
| 12/10/2025 | Waters Corp. | WAT | Upgrade | Outperform (Peerperform) |
386.16 (383.57) |
-0.67% | Details | |
| 11/21/2025 | Exact Sciences | EXAS | Downgrade | Peerperform (Outperform) |
86.18 (104.91) |
21.73% | Details | |
| 10/30/2025 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/25/2025 | Guardant Health | GH | Upgrade | Outperform (Peerperform) |
57.67 (129.69) |
124.88% | Details | |
| 7/21/2025 | Avantor Inc. | AVTR | Maintain | Peerperform (N/A) |
|
Details | ||
| 7/14/2025 | Caris Life Sciences Inc | CAI | New Coverage | Outperform (N/A) |
26.51 (16.72) |
-36.93% | Details | |
| 5/8/2025 | Myriad Genetics | MYGN | Downgrade | Peerperform (Outperform) |
7.27 (4.63) |
-36.31% | Details | |
| 4/29/2025 | Repligen | RGEN | Upgrade | Outperform (Peerperform) |
143.63 (126.37) |
-12.02% | Details | |
| 3/4/2025 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2024 | Stevanato Group S.p.A. | STVN | New Coverage | Outperform (N/A) |
22.47 (16.87) |
-24.92% | Details | |
| 12/13/2024 | West Pharmaceutical | WST | New Coverage | Peerperform (N/A) |
331.62 (336.39) |
1.44% | Details | |
| 12/13/2024 | Mettler-Toledo | MTD | New Coverage | Peerperform (N/A) |
1276.92 (1156.64) |
-9.42% | Details | |
| 12/13/2024 | Tempus AI Inc | TEM | New Coverage | Outperform (N/A) |
41.99 (48.61) |
15.77% | Details | |
| 12/13/2024 | Twist Bioscience | TWST | New Coverage | Outperform (N/A) |
47.39 (85.00) |
79.36% | Details | |
| 12/13/2024 | Hologic | HOLX | New Coverage | Peerperform (N/A) |
75.09 (76.01) |
1.23% | Details | |
| 11/26/2024 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/15/2024 | GRAIL, Inc. | GRAL | New Coverage | Peerperform (N/A) |
15.81 (61.11) |
286.53% | Details | |
| 11/15/2024 | Veracyte, Inc | VCYT | New Coverage | Outperform (N/A) |
37.04 (53.79) |
45.22% | Details | |
| 11/14/2024 | Maravai LifeScience Holdings Inc. | MRVI | New Coverage | Peerperform (N/A) |
5.63 (5.37) |
-4.62% | Details | |
| 11/14/2024 | Repligen | RGEN | New Coverage | Peerperform (N/A) |
150.47 (126.37) |
-16.02% | Details | |
| 11/4/2024 | Danaher | DHR | Upgrade | Outperform (Peerperform) |
245.66 (178.97) |
-27.15% | Details | |
| 10/31/2024 | Danaher | DHR | Upgrade | Outperform (Peerperform) |
242.32 (245.66) |
1.38% | Details | |
| 9/30/2024 | Bruker | BRKR | Downgrade | Peerperform (Outperform) |
70.67 (45.36) |
-35.81% | Details | |
| 8/21/2024 | Myriad Genetics | MYGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/27/2024 | Agilent | A | Downgrade | Peerperform (Outperform) |
134.69 (126.67) |
-5.95% | Details | |
| 6/27/2024 | Qiagen NV | QGEN | Upgrade | Outperform (Peerperform) |
41.04 (37.20) |
-9.36% | Details | |
| 6/27/2024 | 10X Genomics | TXG | Downgrade | Peerperform (Outperform) |
19.59 (31.87) |
62.69% | Details | |
| 6/25/2024 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/6/2024 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/8/2024 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 2/29/2024 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2023 | Guardant Health | GH | New Coverage | Peerperform (N/A) |
26.55 (57.67) |
117.21% | Details | |
| 12/13/2023 | Natera | NTRA | New Coverage | Outperform (N/A) |
56.70 (234.76) |
314.04% | Details | |
| 12/13/2023 | Bruker | BRKR | New Coverage | Outperform (N/A) |
69.24 (70.67) |
2.07% | Details | |
| 12/13/2023 | Myriad Genetics | MYGN | New Coverage | Outperform (N/A) |
19.05 (4.63) |
-75.7% | Details | |
| 12/13/2023 | 10X Genomics | TXG | New Coverage | Outperform (N/A) |
48.14 (31.87) |
-33.8% | Details | |
| 12/13/2023 | Exact Sciences | EXAS | New Coverage | Outperform (N/A) |
65.06 (86.18) |
32.46% | Details | |
| 12/13/2023 | Illumina | ILMN | New Coverage | Outperform (N/A) |
117.64 (164.93) |
40.2% | Details | |
| 12/13/2023 | Pacific Biosciences of California | PACB | New Coverage | Peerperform (N/A) |
8.39 (1.31) |
-84.39% | Details | |
| 12/13/2023 | Waters Corp. | WAT | New Coverage | Peerperform (N/A) |
296.37 (386.16) |
30.3% | Details | |
| 12/13/2023 | Avantor Inc. | AVTR | New Coverage | Peerperform (N/A) |
21.17 (9.43) |
-55.46% | Details | |
| 12/13/2023 | Danaher | DHR | New Coverage | Peerperform (N/A) |
221.35 (242.32) |
9.47% | Details | |
| 12/12/2023 | Thermo Fisher Scientific | TMO | New Coverage | Outperform (N/A) |
494.99 (469.35) |
-5.18% | Details | |
| 12/12/2023 | Qiagen NV | QGEN | New Coverage | Peerperform (N/A) |
42.08 (37.20) |
-11.6% | Details | |
| 12/12/2023 | Agilent | A | New Coverage | Outperform (N/A) |
128.97 (126.67) |
-1.78% | Details | |
| 12/12/2023 | Revvity Inc | RVTY | New Coverage | Peerperform (N/A) |
90.69 (99.90) |
10.16% | Details |
